Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2011-01-25
2011-01-25
Ton, Thaian N (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093210
Reexamination Certificate
active
07875275
ABSTRACT:
The present invention is directed to the use of Bridge-1 polynucleotides and Bridge-1 polypeptides, as well as activators and inhibitors of Bridge-1 activity, in the treatment of Bridge-1 mediated disorders, including diabetes.
REFERENCES:
patent: 4690918 (1987-09-01), Beppu et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: WO 93/25234 (1993-12-01), None
patent: WO 94/06920 (1994-03-01), None
patent: WO 0065052 (2000-11-01), None
Thomas et al. Mol. & Cell. Bio., 19(12): 8492-8504, Dec. 1999.
Thomas et al. Mol. And Cell. Bio., 19(12): 8492-8504, 1999.
Ahlgren, U., et al., “β-Cell-specific inactivation of the mouse Ipfl/Pdxl gene results in loss of the β-cell phenotype and maturity onset diabetes,”Genes Dev12: 1763-1768, Cold Spring Harbor Laboratory Press, US (1998).
Alt, M. and Caselmann, W.H., “Liver-directed gene therapy: molecular tools and current preclinical and clinical studies,”J Hepatol23: 746-758, Elsevier, UK (1995).
Andreassen, O.A., et al., “Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression,”Neurobiol Dis11: 410-424, Elsevier Sience, US (2003).
Antinozzi, P.A., et al., “Metabolic Engineering with Recombinant Adenoviruses,”Annu Rev Nutr19: 511-544, Annual Reviews, US (1999).
Asahara, H., et al. “Pbx-Hox Heterodimers Recruit Coactivator-Corepressor Complexes in an Isoform-Specific Manner,”Mol Cell Biol19(12): 8219-8225, American Society for Microbiology, US (1999).
Berkner, K.L., “Development of Adenovirus Vectors for the Expression of Heterologous Genes,”Bio Techniques6(7): 616-629, Informa BioSciences, US (1988).
Ahlgren, U., et al., “β-Cell-specific inactivation of the mouseIpf1/Pdx1gene results in loss of the β-cell phenotype and maturity onset diabetes,”Genes Dev12: 1763-1768, Cold Spring Harbor Laboratory Press, US (1998).
Brody, S.L. and Crystal, R.G., “Adenovirus-Mediated in Vivo Gene Transfer,”Ann NY Acad Sci716: 90-101, New York Academy of Sciences, US (1994).
Brü{umlaut over (,)}ning, J.C., et al., “Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous forIRandIRS-1Null Alleles,”Cell88: 561-572, Cell Press, US (1997).
Butler, A.E., et al., “Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes,”Diabetes52: 2304-2314, American Diabetes Association, US (2003).
Chakrabarti, S.K., et al., “Covalent Histone Modifications Underlie the Developmental Regulation of Insulin Gene Transcription in Pancreatic β Cells,”J Biol Chem278(26): 23617-23623, The American Society for Biochemistry and Molecular Biology, US (2003).
Chan, H.M. and La Thangue, N.B., “p300/CBP proteins: HATs for transcriptional bridges and scaffolds,”J Cell Sci114: 2363-2373, The Company of Biologists Ltd, UK (2001).
Chen, J., et al., “Role of Akt/protein kinase B in the activity of transciptional coactivator p300,”Cell Mol Life Sci61: 1675-1683, Birkhäuser Verlag, DE (2004).
Chen, S., et al., “Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo,”Proc Natl Acad SciUSA 91: 3054-3057, National Academy of Science, US (1994).
Conaway, R.C., et al., “Emerging Roles of Ubiquitin in Transcription Regulation,”Science296: 1254-1258, American Association for the Advancement of Science, US (2002).
Demartino, G.N., et al., “Identification, Purification, and Characterization of a PA700-dependent Activator of the Proteasome,”J Biol Chem271(6): 3112-3118, The American Socitey for Biochemistry and Molecular Biology, Inc., US (1996).
Donath, M.Y. And Halban, P.A., “Decreased beta-cell mass in diabetes: significance, mechanisms, and therapeutic implications,”Diabetologia47: 581-589, Springer-Verlag, DE (2004).
Dor, Y., et al., “Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation,”Nature429: 41-46, Nature Publishing Group, UK (2004).
Edgar, B.A., “From small flies come big discoveries about size control,”Nat Cell Biol7: E191-E193, Macmillan Magazines Ltd, UK (1999).
Eeckhoute, J., et al., “Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4α (HNF4α) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator,”Mol Endocrinol15(7): 1200-1210, The Endocrine Society, US (2001).
Ehm, M.G., et al., “Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations,”Am J Hum Genet66: 1871-1881, The American Society of Human Genetics, US (2000).
Etienne-Julan, M., et al., “The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker,”J Gen Virol73: 3251-3255, SGM, UK (1992).
Fajans, S.S., et al., “Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young,”N Engl J Med345(13): 971-980, Massachusetts Medical Society, US (2001).
Ferry, N. and Heard, J.M., “Liver-Directed Gene Transfer Vectors,”Hum Gene Ther9: 1975-1981, Mary Ann Liebert, Inc., US (1998).
Flotte, T.R., et al., “Expression of the Cystic Fibrosis Transmembrane Conductance Regulator from a Novel Adeno-associated Virus Promoter,”J Biol Chem268(5): 3781-3790, The American Society for Biochemistry and Molecular Biology, Inc., US (1993).
Flotte, T.R., et al., “Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells,”Am J Respir Cell Mol Biol7: 349-356, American Thoratic Society, US (1992).
Frayling, T.M., et al., “A Genome-Wide Scan in Families With Maturity-Onset Diabetes of the Young,”Diabetes52: 872-881, American Diabetes Association, US (2003).
Gerich, J.E., “Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus,”Mayo Clin Proc78: 447-456, Mayo Foundation for Medical Education and Research, US (2003).
Giles, R.H., et al., “Conjunction dysfunction: CBP/p300 in human disease,”TIG14(5): 178-83, Elsevier Science Ltd, UK (1998).
Gonzalez, F., et al., “Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter,”Science296: 548-550, American Association for the Advancement of Science, US (2002).
Goud, B., et al., “Antibody-Mediated Binding of a Murine Ecotropic Moloney Retroviral Vector to Human Cells Allows Internalization But Not the Establishment of the Proviral State,”Virol163: 251-254, Academic Press, Inc., US (1988).
Graham, F.L. and Prevec, L., “Manipulation of Adenovirus Vectors,” inMethods in Molecular Biology, E.J. Murray, Ed., vol. 7, pp. 109-127, Humana, Clifton N.J., 1991.
Grossman, S.R., et al., “p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation,”Mol Cell2: 405-415, Cell Press, US (1998).
Grossman, S.R., et al., “Polyubiquination of p53 by a Ubiquitin Ligase Activity of p300,”Science300: 342-344, American Association for the Advancement of Science, US (2003).
Haj-Ahmad, Y., et al., “Development of a Helper-Independent Human Adenovirus Vector and Its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene,”J Virol57(1): 267-274, American Society for Microbiology, US (1986).
Hara, K., et al., “A genetic variation in thePGC-1gene could confer insulin resistance and susceptibility to Type II diabetes,”Diabetologia45: 740-743, Springer-Verlag, DE (2002).
Hermonat, P.L., et al., “Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells,”Proc Natl Acad Sci USA81: 6466-6470, National Academy of Science, US (1984).
Hussain
Banz Constanze
Habener Joel F.
Thomas Melissa K.
Sterne Kessler Goldstein & Fox P.L.L.C.
The General Hospital Corporation
Ton Thaian N
LandOfFree
Use of Bridge-1 and activators and inhibitors thereof in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Bridge-1 and activators and inhibitors thereof in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Bridge-1 and activators and inhibitors thereof in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725052